BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37976029)

  • 21. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas.
    de Haas T; Oussoren E; Grajkowska W; Perek-Polnik M; Popovic M; Zadravec-Zaletel L; Perera M; Corte G; Wirths O; van Sluis P; Pietsch T; Troost D; Baas F; Versteeg R; Kool M
    J Neuropathol Exp Neurol; 2006 Feb; 65(2):176-86. PubMed ID: 16462208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression.
    Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Yu H; Qi L
    J Exp Clin Cancer Res; 2019 Dec; 38(1):486. PubMed ID: 31823805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
    Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y
    Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic amplification of orthodenticle homologue 2 in medulloblastomas.
    Boon K; Eberhart CG; Riggins GJ
    Cancer Res; 2005 Feb; 65(3):703-7. PubMed ID: 15705863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164.
    Shi JA; Lu DL; Huang X; Tan W
    Int J Mol Med; 2014 Jul; 34(1):237-43. PubMed ID: 24756834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.
    Ferrucci V; de Antonellis P; Pennino FP; Asadzadeh F; Virgilio A; Montanaro D; Galeone A; Boffa I; Pisano I; Scognamiglio I; Navas L; Diana D; Pedone E; Gargiulo S; Gramanzini M; Brunetti A; Danielson L; Carotenuto M; Liguori L; Verrico A; Quaglietta L; Errico ME; Del Monaco V; D'Argenio V; Tirone F; Mastronuzzi A; Donofrio V; Giangaspero F; Picard D; Remke M; Garzia L; Daniels C; Delattre O; Swartling FJ; Weiss WA; Salvatore F; Fattorusso R; Chesler L; Taylor MD; Cinalli G; Zollo M
    Brain; 2018 May; 141(5):1300-1319. PubMed ID: 29490009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA
    Guo Q; Zhang Q; Lu L; Xu Y
    Cell Cycle; 2020 May; 19(10):1222-1235. PubMed ID: 32264732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.
    Di C; Liao S; Adamson DC; Parrett TJ; Broderick DK; Shi Q; Lengauer C; Cummins JM; Velculescu VE; Fults DW; McLendon RE; Bigner DD; Yan H
    Cancer Res; 2005 Feb; 65(3):919-24. PubMed ID: 15705891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA CCAT1 promotes cell proliferation and metastasis in human medulloblastoma via MAPK pathway.
    Gao R; Zhang R; Zhang C; Zhao L; Zhang Y
    Tumori; 2018; 104(1):43-50. PubMed ID: 28777430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cells.
    Wortham M; Jin G; Sun JL; Bigner DD; He Y; Yan H
    PLoS One; 2012; 7(4):e36211. PubMed ID: 22558385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.
    Jenkins NC; Rao G; Eberhart CG; Pedone CA; Dubuc AM; Fults DW
    J Neurooncol; 2016 Feb; 126(3):415-24. PubMed ID: 26518543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Long Noncoding RNA CRNDE Increases Chemosensitivity of Medulloblastoma Cells by Targeting miR-29c-3p.
    Sun XH; Fan WJ; An ZJ; Sun Y
    Oncol Res; 2020 Feb; 28(1):95-102. PubMed ID: 31753063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA HOTAIR promotes medulloblastoma growth, migration and invasion by sponging miR-1/miR-206 and targeting YY1.
    Zhang J; Li N; Fu J; Zhou W
    Biomed Pharmacother; 2020 Apr; 124():109887. PubMed ID: 31986414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
    Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
    Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced expression of lncRNA TP73-AS1 predicts unfavorable prognosis for gastric cancer and promotes cell migration and invasion by induction of EMT.
    Zhang W; Zhai Y; Wang W; Cao M; Ma C
    Gene; 2018 Dec; 678():377-383. PubMed ID: 30118890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.
    Diaz RJ; Golbourn B; Faria C; Picard D; Shih D; Raynaud D; Leadly M; MacKenzie D; Bryant M; Bebenek M; Smith CA; Taylor MD; Huang A; Rutka JT
    Oncotarget; 2015 Feb; 6(5):3359-74. PubMed ID: 25739120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1.
    Gao J; Dai C; Yu X; Yin XB; Liao WJ; Huang Y; Zhou F
    Gene Ther; 2021 Jun; 28(6):306-318. PubMed ID: 32917950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of LncRNA CARD8-AS1 as a Potential Prognostic Biomarker Associated With Progression of Lung Adenocarcinoma.
    Ji Y; Zhang G; Zhang X
    Br J Biomed Sci; 2022; 79():10498. PubMed ID: 35996500
    [No Abstract]   [Full Text] [Related]  

  • 39. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
    Fan L; Li H; Wang W
    Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.